Amlo

Quick links to important sections

Amlo

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amlo

What is Amlo? (Amlodipine Identity)

Property Description
Active ingredient Amlodipine (besylate)
Form Oral tablets
Pharmacological class Calcium channel blocker (CCB)
Common purpose Managing blood pressure and supporting heart function
Origin Synthetic compound

What Type of Medicine is Amlo?

Amlo is the commercial designation for the active pharmaceutical ingredient Amlodipine, which is formally classified as a Calcium channel blocker (CCB). This medication belongs specifically to the dihydropyridine subclass of CCBs, a group of agents primarily used to manage conditions related to the circulatory system. This classification dictates that the drug's fundamental function is based on modulating the passage of calcium ions within the body's vascular structures. As an established antihypertensive agent, Amlodipine is recognized for its role in sustaining healthy blood pressure levels and maintaining adequate blood flow.

Composition, Form, and Origin

The core component of the medicine is the synthetic compound Amlodipine, which is often presented as the stable salt, Amlodipine besylate. The active ingredient Amlodipine is manufactured for oral administration, typically provided in the form of oral tablets, although liquid preparations may also exist. Amlodipine is characterized by a long duration of action, which supports its utility in continuous, long-term therapeutic regimens. This longevity of action means the medicine works steadily over the course of the day following ingestion. The medication is widely available as a single-ingredient product used in monotherapy, but is also frequently included in fixed-dose combination formulations alongside other cardiovascular agents to offer complementary therapeutic benefits.

General Purpose: How Amlodipine Supports the Heart

The general therapeutic purpose of Amlodipine is to alleviate excessive physical strain on the cardiovascular system by promoting the relaxation of blood vessels. By limiting the influx of calcium ions into the vascular smooth muscle, Amlodipine induces widespread peripheral vasodilation, meaning the arteries widen. This effect inherently lowers the overall peripheral vascular resistance, reducing the physical burden on the heart when it pumps blood and supporting consistent, healthy circulation. A typical use scenario involves using Amlodipine for the maintenance therapy of elevated blood pressure in adult patients.

What side effects are possible with Amlo?

Possible Side Effects and Safety Information for Amlo

Amlo (amlodipine) is a calcium channel blocker whose safety profile is well-characterized in regulatory documents. Adverse reactions are primarily related to its blood vessel-widening (vasodilatory) effects.

Common Adverse Reactions and Dose-Related Effects

The most frequent side effect is edema (swelling of the hands, feet, or ankles), which is explicitly documented as occurring in a dose-related manner. Other adverse reactions reported in clinical trials with an incidence greater than 1% include headache, fatigue, nausea, abdominal pain, and dizziness.

Serious and Clinically Significant Safety Information

Official labeling contains warnings regarding potentially serious but rare events. Worsening angina (chest pain) and acute myocardial infarction (heart attack) can occur upon initiation of the drug or when the dosage is increased, particularly in patients with severe obstructive coronary artery disease. Symptomatic hypotension (low blood pressure causing symptoms like light-headedness) is a possible risk, especially in patients with severe aortic stenosis. Rare postmarketing reports include serious reactions such as allergic events (e.g., angioedema) and pancreatitis.

Safety Restrictions and Population Considerations

Amlodipine is contraindicated in patients with known sensitivity to the drug, cardiogenic shock, and severe aortic stenosis. Caution is advised when the drug is used in patients with congestive heart failure (due to increased risk of pulmonary edema) and in those with hepatic impairment (liver disease), as drug clearance is reduced, often necessitating a lower starting dose.


Regulatory Safety Summary: The official safety profile is dominated by the common, dose-dependent occurrence of peripheral edema. The structure of the warnings focuses on vigilance for cardiovascular events upon initiating therapy and mandates caution in populations with specific pre-existing heart or liver conditions due to altered drug clearance or heightened risk.

Overdose and Emergency Response

Overdose and When to Seek Help

The official overdose profile for Amlo (Amlodipine) is defined by an exaggerated cardiovascular effect resulting from its classification as a calcium channel blocker. Regulatory documents note that experience with intentional overdose in humans is limited.

Overdose Risk & Signs Emergency Actions Required
Profound Hypotension: Critically low blood pressure (shock) is the principal manifestation. Call emergency services immediately (e.g., 911) if the person has collapsed, had a seizure, has trouble breathing, or cannot be awakened.
Documented Manifestations: Other recognized signs include dizziness, fainting, and rapid heartbeat (tachycardia). Contact the Poison Control Helpline to obtain guidance regarding exposure.

Official Overdose Response

Overdose can lead to life-threatening outcomes, including collapse and seizure. The official response framework relies on symptomatic and supportive treatment, as no specific antidote is known. The management of excessive hypotension is described in regulatory labeling. This includes procedural steps such as placing the person in a supine position and administering an intravenous infusion of normal saline to help stabilize blood pressure. Individuals experiencing documented overdose manifestations, such as profound hypotension or fainting, must seek immediate medical attention.

Therapeutic Uses of Amlo

What Amlo Treats: Main Uses and Benefits

Amlodipine is commonly used to help with symptoms related to systemic imbalance within cardiovascular contexts. Its use may be part of symptomatic management applied across domains where additional symptomatic support is needed.

This medication is commonly used to help with symptoms related to systemic imbalance, specifically persistent high blood pressure (hypertension), and symptoms related to physical discomfort. Amlodipine is applied across therapeutic domains where additional symptomatic support is needed, including the management of hypertension, chronic stable angina, and vasospastic angina (a type of chest pain).

“It is commonly used when short-term symptomatic assistance is needed and helps maintain a sense of stability when symptoms are more noticeable.”


Daily Management of Chronic High Blood Pressure

This block covers the drug’s role in helping to manage elevated arterial pressure, a condition marked by increased physiological stress. The therapeutic benefit is associated with long-term support for systemic balance. This continuous management supports the handling of symptoms related to systemic imbalance, which may assist with general well-being in conditions where symptoms may intensify temporarily.


Prophylactic Relief of Angina and Symptom Support

Amlo is relevant for easing symptoms related to physical discomfort associated with angina pectoris, and may assist with managing symptoms linked to organ-specific functional stress. This supportive role helps address symptom clusters that interfere with daily functioning, and contributes to improved comfort during periods of heightened symptoms.


Quick Fact: Relief for Anginal Chest Discomfort Amlodipine is commonly used to help ease symptoms related to physical discomfort associated with angina.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility for Amlodipine Use

Amlodipine is contraindicated and must not be used in patients with known hypersensitivity to the drug itself or to other dihydropyridine derivatives. Absolute prohibitions also apply to individuals experiencing severe hypotension, shock (including cardiogenic shock), or those with obstruction of the left ventricular outflow tract (e.g., severe aortic stenosis).

Age Group Regulatory Eligibility Status
Adults Approved for general use.
Pediatric (6 to 17 years) Approved for hypertension treatment.
Pediatric (Under 6 years) Safety and effectiveness have not been established.

Use is restricted in several populations. Patients with impaired hepatic function require administration with caution, and a slower dose titration is advised for those with severe hepatic impairment. Dose adjustments are generally not required for patients with renal impairment. For pregnancy, use is only recommended if the potential benefit justifies the risk to the fetus. For lactation, the official status advises a decision to discontinue nursing or discontinue the drug.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents detail specific interactions for Amlodipine, primarily related to pharmacokinetic and pharmacodynamic effects.

Interaction Classifications

Classification Regulatory Information
Severity Contraindicated (Dantrolene), Significant Interaction (CYP3A4 Inhibitors, Simvastatin), Additive Effect (Antihypertensives)
Regulatory Basis FDA Prescribing Information and EMA Summary of Product Characteristics (SmPC)

Official Interaction Statements

The co-administration of Dantrolene (intravenous) is formally contraindicated due to the reported risk of hyperkalemia.

Metabolic Pathway Interaction (CYP3A4): Co-administration with strong or moderate CYP3A4 inhibitors (e.g., Itraconazole, Clarithromycin) significantly increases Amlodipine exposure. Conversely, strong CYP3A4 inducers (e.g., Rifampicin, St. John's wort) can reduce Amlodipine plasma concentrations, potentially causing a loss of therapeutic effect.

Exposure-Restricted Combination: Amlodipine increases the exposure of Simvastatin. Regulatory labeling requires the Simvastatin dosage to be limited to a maximum of 20 mg per day when co-administered.

Pharmacodynamic Interaction: The addition of Amlodipine to other antihypertensive agents, including PDE5 inhibitors (e.g., Sildenafil), results in additive blood pressure lowering effects.

Food/Substance Interaction: Consumption of grapefruit or grapefruit juice is not recommended as it may increase Amlodipine's systemic exposure.

Population Note: Increased systemic exposure and risk of interaction are officially noted for patients with hepatic impairment due to decreased drug clearance.

Mechanism of Action

Amlo is a pharmacological agent that exerts its effect by selectively binding to and blocking voltage-dependent L-type calcium channels (Cav1.2). These specific channels are located predominantly on the membranes of vascular smooth muscle cells and, to a lesser extent, on cardiac muscle cells.

The binding action inhibits the transmembrane influx of extracellular calcium ions into the cell cytoplasm. The resulting reduction in intracellular calcium concentration prevents the full activation of the smooth muscle contractile machinery.

This molecular and intracellular cascade leads to peripheral arterial vasodilation and a subsequent reduction in peripheral vascular resistance. This physiological modulation directly interferes with the regulatory pathways governing vascular tone, resulting in decreased arterial pressure.

Dosage and Administration Information

Amlodipine (Amlo) is designed for long-term, once-daily oral administration. The use of the medication involves specific parameters regarding dosage, frequency, and administration conditions.

Standard Dosing and Administration

Category Instructions
Route of Administration For oral use only, typically in the form of tablets or oral solution/suspension.
Standard Adult Dose The usual starting dose is 5 mg once daily; the maximum daily dose is 10 mg.
Dosing Frequency & Timing Must be taken once daily at approximately the same time each day, and can be administered with or without food.
Dose Titration Dosage adjustments, if necessary, should generally be performed slowly, waiting 7 to 14 days to fully assess the patient's response to each dose level.
Special Populations A lower starting dose of 2.5 mg once daily is suggested for small, fragile, or older adult patients, and those with hepatic impairment.
Pediatric Dosing The recommended oral dose for children aged 6–17 years is 2.5 mg to 5 mg once daily. Doses exceeding 5 mg daily have not been studied in this population.
Missed Dose If a dose is missed, it should be taken as soon as possible, unless it is almost time for the next dose (e.g., if less than 12 hours remain); do not double the dose.

These instructions structure the use of Amlodipine by establishing a consistent daily schedule and defining specific initial and maximum dose tiers. The protocol involves slow titration and provides specific lower starting doses for vulnerable populations to ensure standardized use.

Recent Clinical Evidence

Research evidence / Overview of studies for Amlo (Amlodipine)


Evidence for use in Essential Hypertension (High Blood Pressure)

This section will summarize the structure of the clinical research for Amlodipine's use in managing high blood pressure, detailing the types of large-scale studies (such as randomized controlled trials and meta-analyses) that exist and the specific blood pressure and cardiovascular outcomes that were measured.

Amlodipine was evaluated in research exploring elevated blood pressure primarily through large-scale randomized controlled trials (RCTs). These studies included wide groups of adults with varying degrees of high blood pressure. Researchers monitored the main outcomes of interest, which included measurements in both the upper and lower blood pressure readings (systolic and diastolic) and whether people achieved target blood pressure goals. Longer-duration trials also examined outcomes related to major cardiovascular events (such as stroke or heart attack) over time.

Findings from this extensive research describe patterns related to blood pressure measurements across diverse adult cohorts. The available evidence, synthesized across multiple studies, contributes to the discussion of symptom patterns regarding how blood pressure levels are tracked and studied over both short and long periods.

What remains uncertain for this indication relates mainly to specific population details. While a large volume of research has been conducted for adults, data for very young children (under the age of 6 years) remain insufficient. Also, some studies explored whether different patterns were observed in certain high-risk patient groups when Amlodipine was studied alongside a combination therapy.


Evidence for use in Chronic Stable Angina Pectoris (Chest Discomfort)

This block will describe the studies that examined Amlodipine for the treatment of chronic stable chest discomfort. It will outline the types of controlled trials available and the symptomatic and functional outcomes that were evaluated, such as changes in exercise capacity and frequency of discomfort episodes.

Amlodipine was evaluated in controlled trials, including those comparing it to a placebo, in individuals with chronic stable angina pectoris. These studies explored outcomes related to physical discomfort and daily functioning for individuals experiencing this condition. Researchers typically monitored symptomatic measures, such as the frequency of anginal episodes recorded in patient diaries, and the reliance on acute symptom relief medication (like nitroglycerin).

The studies also applied in research examining patient-reported experiences of outcomes reflecting daily functioning or activity level. For instance, researchers tracked how long individuals could exercise before discomfort began, using standardized tests. The reported data from these trials contributes to understanding symptom patterns over short-term observation intervals.

Key Studies & References

  1. Amlodipine in the Treatment of Patients with Stable Angina Pectoris: Evaluation of Efficacy and Tolerability Based on Cycle Ergometric Stress Testing and 24-Hour Holter Monitoring
  2. Hypertension in adults: diagnosis and management - NICE Guideline [NG136] (Evidence Review sections)
  3. Amlodipine - StatPearls (Overview of Indications, including Vasospastic Angina and Pediatric Use)

Frequently Asked Questions (FAQ)

Common questions about Amlo (FAQ)


Q: Can Amlo cause swelling in the ankles or feet?

Swelling, medically known as edema, of the hands, feet, or ankles is a very common side effect reported in clinical trials involving Amlodipine. According to official product information, this swelling is explicitly documented as occurring in a manner that relates to the dose being taken.


Q: Does Amlo have any known food interactions?

Official documents note that a standard high-fat, high-calorie meal did not significantly affect the way Amlodipine is absorbed by the body. However, regulatory guidelines advise against consuming grapefruit or grapefruit juice, as this substance can interact with the medication.


Q: Is it okay to take Amlo along with vitamins or herbal supplements?

Some herbal supplements, such as St. John's wort, are known as strong CYP3A4 inducers that can potentially reduce the amount of Amlodipine in the bloodstream. Conversely, other supplements or foods acting as strong CYP3A4 inhibitors could increase exposure. Official documentation lists specific known interactions, which highlights the importance of discussing all co-administered products with a healthcare provider.


Q: How long do most people need to stay on Amlo?

Amlodipine is officially designed for long-term, once-daily oral administration for its approved indications, which include high blood pressure and chronic stable angina. Clinical studies have shown that its therapeutic effect is consistently maintained for at least 24 hours with chronic daily use.


Q: What is the typical timeframe before a doctor decides if Amlo is working?

The medication generally reaches steady-state concentrations—meaning a consistent level in the bloodstream—after about seven to eight days of consecutive daily dosing. Official guidelines indicate that dosage adjustments are generally performed slowly, requiring a wait of 7 to 14 days to fully assess a patient's response to the current dose level.


Q: Why do some regulatory bodies have warnings about taking Amlo with grapefruit juice?

Regulatory documents advise against consuming grapefruit or grapefruit juice because it can potentially increase the systemic exposure of Amlodipine. This indicates that a higher amount of the drug may circulate in the bloodstream.


Q: Is it true that Amlo is sometimes used to treat a type of chest pain?

Yes, in addition to treating high blood pressure, official labeling indicates that Amlo is approved for the symptomatic treatment of chronic stable angina and vasospastic (Prinzmetal's or variant) angina. These are both conditions characterized by chest pain.


Q: What does 'use with caution' mean for Amlo in official documents?

In regulatory documents, the advice to 'use with caution' indicates that special consideration is needed for certain patient groups. For example, official guidelines recommend using a lower starting dose (2.5 mg) and proceeding with caution for patients with hepatic (liver) impairment because their bodies may process the drug more slowly.


Q: Why do people take Amlo for issues other than blood pressure?

Beyond high blood pressure, Amlo is also indicated for the symptomatic treatment of chronic stable angina and a less common form of chest pain called vasospastic angina. These uses address different aspects of cardiovascular health by helping to ease strain on the heart.


Q: How quickly should Amlo start to have an effect?

The medication reaches its highest concentrations in the bloodstream approximately 6 to 12 hours after it is taken by mouth. Once a consistent daily schedule is established, its therapeutic effect is maintained continuously throughout the 24-hour dosing period.


Q: Is Amlo the same type of drug as [A commonly compared drug, e.g., Lisinopril]?

Amlodipine is formally classified as a dihydropyridine calcium channel blocker. It is a member of the dihydropyridine subclass, which defines its distinct mode of operation.


Q: Are there any common but minor side effects of Amlo I should be aware of?

In addition to swelling, some of the common adverse reactions reported in clinical trials (those occurring in more than 1% of patients) include headache, fatigue, nausea, abdominal pain, and dizziness. These are documented in official prescribing information.


Q: Does taking Amlo make you tired or dizzy?

Yes, dizziness and fatigue (a feeling of excessive tiredness) are both listed among the common adverse reactions that were reported in clinical trials involving Amlodipine.


Q: Is it common for people to gain weight while taking Amlo?

Official regulatory documents, such as the European Summary of Product Characteristics (SmPC), list 'Weight increase' as an Uncommon adverse reaction associated with the use of Amlodipine.


Q: Can Amlo be taken by people with kidney problems?

Regulatory information indicates that having renal impairment (kidney problems) does not significantly change how the body processes Amlodipine. For this reason, a dose adjustment is generally not required for patients with kidney problems.


Q: Is Amlo safe for people who have diabetes?

The product label notes that the absolute benefit of managing blood pressure is greater in patients who are considered high risk, which includes those with conditions like diabetes. The drug is used as part of comprehensive risk management.


Q: Does Amlo affect cholesterol levels?

While Amlodipine is not specifically a cholesterol-lowering drug, its role in managing blood pressure is considered part of comprehensive cardiovascular risk management. This broader management often includes addressing factors like lipid (cholesterol) control.


Q: Is Amlo suitable for use by older adults?

Official guidelines recommend starting the dosage at the low end of the therapeutic range (2.5 mg once daily) for older adult patients. A lower starting dose is also advised for small, fragile patients and those with liver impairment.


Q: Are there any known issues with taking Amlo while trying to conceive?

Official regulatory sources note that Amlodipine may affect sperm function in males. This is noted in regulatory documents regarding male patients and fertility.


Q: Is Amlo a beta-blocker?

No, Amlodipine is formally classified as a dihydropyridine calcium channel blocker. This is a different class of medication from a beta-blocker.


Q: What did the main clinical trials for Amlo focus on?

The key clinical trials primarily focused on scientifically measuring changes in blood pressure (both systolic and diastolic readings), the reduction in frequency of angina (chest pain) attacks, and increases in the amount of exercise time a person could manage.


Q: How is Amlo's safety profile generally described in official sources?

The official safety profile is characterized by common, often dose-related effects such as edema and headache. It also includes official warnings for rare but serious cardiovascular events, such as worsening angina or heart attack, that can occur when starting the medication or increasing the dose.


Q: Is it normal to feel a change in heart rhythm after starting Amlo?

Official adverse reaction reports from clinical trials indicate that palpitations—a feeling of having a fast, irregular, pounding, or racing heartbeat—were reported by some patients during the use of Amlodipine.


Q: Does Amlo impact exercise tolerance?

Studies documented in official information show that for patients with a condition known as exertional angina (chest pain brought on by activity), Amlodipine was shown to increase the symptom-limited exercise time in several clinical trials.


Q: What is the evidence regarding Amlo's use in younger patients?

A recommended oral dose is established for children aged 6 to 17 years for the treatment of hypertension. However, official safety and effectiveness have not been established for children younger than 6 years of age.


Q: Is Amlo linked to headaches?

Yes, headache is listed among the most common adverse reactions that were reported in clinical trials involving Amlodipine, with an incidence greater than 1%.


Q: Are there special considerations for taking Amlo in hot weather?

Official information indicates that consideration should be given to factors such as hot weather or exercise. This is because heavy sweating can lead to fluid loss and potentially result in low blood pressure, which may cause feelings of dizziness or lightheadedness.


Q: How does Amlo compare to ACE inhibitors in terms of mechanism?

Amlo is a calcium channel blocker that works by inhibiting the flow of calcium ions into muscle cells to promote blood vessel widening. This is a mechanism that is fundamentally distinct from the action of ACE inhibitors, which work on a different pathway involving certain hormones.


Q: What research exists about the long-term effectiveness of Amlo?

The sustained efficacy (ability to maintain its effectiveness) of Amlodipine has been demonstrated over long-term dosing in patients with angina. Similarly, its blood pressure lowering effect is officially documented as being maintained for at least 24 hours with chronic daily oral administration.


Q: Can Amlo cause skin sensitivity to the sun?

Official product documents, such as the SmPC, note that rare dermatological reactions have been reported, including a rash that may involve photosensitivity (an increased sensitivity of the skin to sunlight).

How should Amlo be stored and disposed of?

Amlodipine tablets must be stored according to official regulatory requirements to maintain product stability and safety.

Official Storage Conditions

Amlodipine must be stored at controlled room temperature, typically between 20°C and 25°C (68°F and 77°F), with permitted excursions up to 30°C. The medication must be protected from light, excess heat, and moisture. It is required to keep the product from freezing.

Packaging and Child Safety

The tablets should be kept in the original container, tightly closed and stored out of sight and reach of children.

Disposal Instructions

Unused or expired product should be disposed of according to local regulations, preferably through a medicine take-back program. Regulatory guidance advises not to flush the tablets down the toilet; household disposal is permitted only after mixing the medicine with an unappealing substance.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amlo found in:

A-Z Index: